{{Rsnum
|rsid=2131109
|Gene=BSN
|Chromosome=3
|position=49667554
|Orientation=minus
|GMAF=0.41
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BSN
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 22.1 | 48.7 | 29.2
| HCB | 0.0 | 11.7 | 88.3
| JPT | 0.0 | 8.8 | 91.2
| YRI | 42.9 | 40.8 | 16.3
| ASW | 38.6 | 54.4 | 7.0
| CHB | 0.0 | 11.7 | 88.3
| CHD | 1.8 | 11.0 | 87.2
| GIH | 5.9 | 38.6 | 55.4
| LWK | 69.1 | 29.1 | 1.8
| MEX | 8.6 | 48.3 | 43.1
| MKK | 66.0 | 27.6 | 6.4
| TSI | 25.5 | 48.0 | 26.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=19657358
|Title=Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility
}}

{{PMID Auto
|PMID=20307617
|Title=Association analysis of 3p21 with Crohn's disease in a New Zealand population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}